https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/?page=59

Filter by:

Biomedical Research Centre news

Phase I clinical trial utilising CAR T cells to treat refractory neuroblastoma has opened at GOSH

28 Jun 2016, 2:15 p.m.

A Phase I clinical trial of T-cell immunotherapy for relapsed or refractory neuroblastoma has opened at Great Ormond Street Hospital (GOSH).

Clinical trial to investigate treatment of acute lymphoblastic leukaemia to open at GOSH

28 Jun 2016, 2:12 p.m.

A Phase I clinical trial (CARPALL) has opened at Great Ormond Street Hospital (GOSH) to investigate the use of immunotherapy with genetically modified T cells for acute lymphoblastic leukemia (ALL). The trial is led by Professor Persis Amrolia, who is sup

Reduced risk of pulmonary embolism in children treated with long term parenteral nutrition

28 Jun 2016, 2:08 p.m.

Researchers at Great Ormond Street Hospital (GOSH) have shown a reduction in the incidence of pulmonary embolism in patients receiving parenteral nutrition after the introduction of a new mixed intravenous lipid emulsion.

Biomarin release results from CLN2 trial being carried out at GOSH

28 Jun 2016, 2:05 p.m.

Biomarin have released positive 48-week results from a clinical trial of cerliponase alfa treatment for CLN2 disease.

Dr Wendy Heywood awarded investigator initiated research proposal from Shire Pharmaceuticals

28 Jun 2016, 2:01 p.m.

Following NIHR Great Ormond Street BRC support, which led to the creation of a high-throughput targeted proteomic urine test, Dr Wendy Heywood has been awarded an industry investigator initiated award from Shire Pharmaceuticals.